改良DCF方案与XELOX方案对晚期胃癌的临床效果观察(4)
[18]董宁宁,王明玉,张琼,等.奥沙利铂联合卡培他滨一线治疗进展期胃癌的临床疗效观察[J].癌症,2009,28(4):412-415.
[19]韦淑贞,张闯,朱婧妮,等.奥沙利铂联合卡培他滨一线治疗进展期胃癌疗效观察[J].现代肿瘤医学, 2014,22(1):118-120.
[20]Yang T,Shen X,Tang X,et al.Phase Ⅱtrial of oxaliplatin plus oral capecitabine as first-line chemotherapy for patients with advanced gastric cancer[J].Tumori,2011, 97(4):466-472.
[21]Kuo YC,Liu HT,Lin YL,et al.Modified biweekly oxaliplatin and capecitabine for advanced gastric cancer: a retrospective analysis from a medical center[J].Biomed J,2014,37(3):141-146.
[22]Xiang XJ,Zhang L,Qiu F,et al.A phase Ⅱ study of capecitabine plus oxaliplatin as first-line chemotherapy in elderly patients with advanced gastric cancer[J].Chemotherapy,2012.,58(1):1-7.
[23]张昉,陈雅敏,荆超,等.改良DCF方案与FOLFOX 4方案治疗晚期胃癌的临床疗效[J].临床肿瘤学杂志,2014, 19(3):231-234.
[24]尹洪岩,石燕,吴志勇,等.改良DCF与XELOX方案治疗老年晚期胃癌的疗效及安全性分析[J].中国药物应用与监测,2016,13(2):69-73.
[25]李开春,王静文,唐曦.从循证医学看老年晚期胃癌一线化疗的选择[J].中国肿瘤,2015,(4):314-318.
(收稿日期:2016-07-08 本文编辑:顾雪菲) (侯娟 崔丽华 吴志伟 黄余峰)
[19]韦淑贞,张闯,朱婧妮,等.奥沙利铂联合卡培他滨一线治疗进展期胃癌疗效观察[J].现代肿瘤医学, 2014,22(1):118-120.
[20]Yang T,Shen X,Tang X,et al.Phase Ⅱtrial of oxaliplatin plus oral capecitabine as first-line chemotherapy for patients with advanced gastric cancer[J].Tumori,2011, 97(4):466-472.
[21]Kuo YC,Liu HT,Lin YL,et al.Modified biweekly oxaliplatin and capecitabine for advanced gastric cancer: a retrospective analysis from a medical center[J].Biomed J,2014,37(3):141-146.
[22]Xiang XJ,Zhang L,Qiu F,et al.A phase Ⅱ study of capecitabine plus oxaliplatin as first-line chemotherapy in elderly patients with advanced gastric cancer[J].Chemotherapy,2012.,58(1):1-7.
[23]张昉,陈雅敏,荆超,等.改良DCF方案与FOLFOX 4方案治疗晚期胃癌的临床疗效[J].临床肿瘤学杂志,2014, 19(3):231-234.
[24]尹洪岩,石燕,吴志勇,等.改良DCF与XELOX方案治疗老年晚期胃癌的疗效及安全性分析[J].中国药物应用与监测,2016,13(2):69-73.
[25]李开春,王静文,唐曦.从循证医学看老年晚期胃癌一线化疗的选择[J].中国肿瘤,2015,(4):314-318.
(收稿日期:2016-07-08 本文编辑:顾雪菲) (侯娟 崔丽华 吴志伟 黄余峰)